General Pharmacology Practice Questions

Q: Alcohol, salicylates, and pilocarpine can be used as:

Diaphoretics. **Explanation:** **Diaphoretics** are substances that induce or increase sweating (diaphoresis). The correct answer is **B** because alcohol, salicylates, and pilocarpine all possess mechanisms that stimulate sweat production: 1. **Alcohol:** Acts as a peripheral vasodilator. By dilating cutaneous blood vessels, it increases blood flow to the skin, which stimulates sweat glands. 2. **Salicylates (Aspirin):** These act on the hypothalamic thermostat. In febrile states, they reset the "set-point" and promote heat loss through cutaneous vasodilation and profuse sweating. 3. **Pilocarpine:** A direct-acting cholinergic agonist. It stimulates the M3 muscarinic receptors on eccrine sweat glands, making it one of the most potent secretagogues (used clinically in the "Sweat Test" for Cystic Fibrosis). **Analysis of Incorrect Options:** * **A. Chelating agents:** These are used to bind heavy metals (e.g., EDTA, BAL, Penicillamine). None of the listed drugs function as chelators. * **C. Purging agents (Cathartics):** These accelerate defecation (e.g., Magnesium sulfate, Bisacodyl). While pilocarpine increases GI motility, it is not used as a clinical purgative. * **D. Forced alkaline diuresis:** This technique is used to excrete acidic drugs like **salicylates** and phenobarbitone by alkalinizing the urine with Sodium Bicarbonate. While salicylates are *treated* by this method, they do not *cause* it. **NEET-PG High-Yield Pearls:** * **Pilocarpine** is the drug of choice for the **Sweat Chloride Test** to diagnose Cystic Fibrosis. * **Anticholinergics** (like Atropine) cause "anhydrosis" (suppression of sweat), leading to "Atropine fever," especially in children. * **Salicylate poisoning** presents with a mixed respiratory alkalosis and metabolic acidosis; remember that while they induce sweating, the definitive treatment for toxicity is urinary alkalinization.

Q: Therapeutic drug monitoring of plasma concentration of antihypertensive drugs is not practiced because?

It is easier to measure the effect of these drugs.. ### Explanation **1. Why Option B is Correct:** The primary goal of Therapeutic Drug Monitoring (TDM) is to guide dosage when there is no easily measurable clinical endpoint or when the drug has a narrow therapeutic index. In hypertension, the clinical effect—**Blood Pressure (BP)**—is immediate, objective, and easily measured using a simple sphygmomanometer. Since the physician can directly titrate the drug dose based on the patient’s BP response, measuring plasma concentrations is redundant, expensive, and clinically unnecessary. **2. Analysis of Incorrect Options:** * **Option A:** While some assays are complex, modern chromatography (HPLC/LC-MS) makes drug level determination routine for many substances. The lack of TDM is due to clinical utility, not technical difficulty. * **Option C:** While some drugs exhibit non-linear pharmacokinetics, this would actually be an *indication* for TDM (like Phenytoin), not a reason to avoid it. * **Option D:** Only a few antihypertensives are prodrugs (e.g., Enalapril, Methyldopa). Most commonly used drugs like Amlodipine, Atenolol, and Losartan are active in their ingested form. **3. High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Narrow therapeutic index, poor correlation between dose and plasma level, lack of easily measurable clinical effect, or suspected toxicity/non-compliance. * **Classic Drugs requiring TDM:** Lithium, Digoxin, Phenytoin, Theophylline, Aminoglycosides, and Cyclosporine. * **Exceptions in CVD:** While we don't monitor levels for antihypertensives, we **do** monitor **Digoxin** (narrow therapeutic index) and **Warfarin** (via PT/INR, a surrogate marker of effect). * **Concept:** If the "pharmacological effect" is easily measurable (e.g., BP for antihypertensives, Blood Sugar for Insulin, INR for Warfarin), TDM of plasma concentration is generally not required.

Q: Fexofenadine is a metabolic product of which of the following drugs?

Terfenadine. ### Explanation **Correct Answer: D. Terfenadine** **Reasoning:** Fexofenadine is the **active acid metabolite** of Terfenadine. Originally, Terfenadine was a popular second-generation H1-antihistamine. However, it was discovered that Terfenadine is a prodrug that undergoes extensive first-pass metabolism in the liver via the **CYP3A4 enzyme** to become Fexofenadine. The medical significance of this conversion is critical for exams: Terfenadine itself is cardiotoxic; it blocks delayed rectifier K+ channels in the heart, leading to **QT interval prolongation** and a life-threatening polymorphic ventricular tachycardia known as **Torsades de Pointes**. This toxicity occurs if CYP3A4 is inhibited (e.g., by erythromycin or ketoconazole). Fexofenadine, however, provides the same antihistaminic benefits without the cardiotoxicity, leading to the withdrawal of Terfenadine from the market. **Analysis of Incorrect Options:** * **A. Loratadine:** It is a prodrug, but its active metabolite is **Desloratadine**. * **B. Astemizole:** Similar to Terfenadine, it was withdrawn due to Torsades de Pointes. Its active metabolite is **Norastemizole**. * **C. Cetirizine:** It is actually the active metabolite of **Hydroxyzine** (a first-generation antihistamine). Cetirizine itself is not a prodrug. **High-Yield Clinical Pearls for NEET-PG:** * **Active Metabolites:** Always remember the pairs: Terfenadine → Fexofenadine; Loratadine → Desloratadine; Hydroxyzine → Cetirizine. * **Safety Profile:** Fexofenadine is considered the least sedating second-generation antihistamine because it does not cross the blood-brain barrier. * **Drug Interactions:** Avoid taking Fexofenadine with fruit juices (like orange or grapefruit) as they inhibit OATP1A2, reducing the drug's absorption.

Q: Which of the following is not a pro-drug?

Penicillin. **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver or gut) into an active metabolite to exert its therapeutic effect. **Why Penicillin G is the correct answer:** Penicillin G (Benzylpenicillin) is an **active drug**. It does not require metabolic activation to exert its antibacterial effect; it directly binds to Penicillin-Binding Proteins (PBPs) to inhibit bacterial cell wall synthesis. Therefore, it is not a prodrug. **Analysis of Incorrect Options:** * **Becampicillin:** It is an ester prodrug of **Ampicillin**. It was developed to improve oral bioavailability and reduce gastrointestinal side effects (like diarrhea) by being absorbed more efficiently before being hydrolyzed into active ampicillin in the intestinal wall or blood. * **Levodopa:** It is the metabolic precursor to **Dopamine**. Dopamine cannot cross the blood-brain barrier (BBB); however, Levodopa crosses the BBB via amino acid transporters and is then converted to active dopamine by the enzyme DOPA decarboxylase. * **Enalapril:** Most ACE inhibitors (except Captopril and Lisinopril) are prodrugs. Enalapril is converted by hepatic esterases into its active form, **Enalaprilat**, which inhibits the Angiotensin-Converting Enzyme. **NEET-PG High-Yield Pearls:** * **Mnemonic for Prodrugs:** "**A**ll **P**ilots **C**an **L**ead **D**rummers **E**very **S**unday" (**A**cyclovir/ACEi, **P**roguanil/PPIs, **C**yclophosphamide, **L**evodopa, **D**ipivefrin, **E**nalapril, **S**ulindac/Statins). * **Exceptions to remember:** **Captopril** and **Lisinopril** are the only two ACE inhibitors that are NOT prodrugs. * **Active Metabolites:** Some drugs are active themselves but also have active metabolites (e.g., Diazepam → Nordiazepam). These are distinct from prodrugs, which are inactive initially.

Q: Which of the following is/are prodrug(s)?

All the above. **Explanation:** A **prodrug** is a pharmacologically inactive compound that is converted into an active metabolite within the body (usually via the liver) to exert its therapeutic effect. This strategy is often used to improve bioavailability, reduce toxicity, or prolong the duration of action. * **Proguanil (Option A):** This is an antimalarial drug that is inactive in its parent form. It is converted by the hepatic enzyme **CYP2C19** into its active metabolite, **Cycloguanil**, which inhibits dihydrofolate reductase in the malaria parasite. * **Azathioprine (Option B):** This is an immunosuppressant used in organ transplants and autoimmune diseases. It is a prodrug that is non-enzymatically converted into **6-Mercaptopurine (6-MP)**, which then undergoes further activation to inhibit purine synthesis. * **Prontosil (Option C):** Historically significant as the first sulfonamide, Prontosil is a red dye that has no antibacterial activity *in vitro*. However, *in vivo*, it is split by bacterial enzymes in the gut to release the active component, **Sulfanilamide**. Since all three drugs require metabolic activation to become effective, **Option D (All the above)** is the correct answer. ### **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Prodrugs:** "All Compounds Can Produce Efficient Medication" (**A**CE inhibitors except Captopril/Lisinopril, **C**yclophosphamide, **C**lopidogrel, **P**roguanil/Prontosil, **E**nalapril, **M**ethyldopa/Levodopa). * **Exceptions to remember:** Most ACE inhibitors are prodrugs **EXCEPT Captopril and Lisinopril**. * **Active Metabolites:** Some drugs are active themselves but also have active metabolites (e.g., Diazepam → Nordiazepam). These are **not** classified as prodrugs.

Q: Which of the following drugs can result in the teratogenic effect shown in the diagram if given during pregnancy?

Retinoic acid. **Explanation:** **Retinoic Acid (Vitamin A derivative)** is a potent teratogen. When administered during the first trimester of pregnancy, it interferes with the migration and differentiation of **cranial neural crest cells**. This leads to a specific pattern of malformations known as **Retinoic Acid Embryopathy**, which typically includes craniofacial abnormalities (microtia/anotia, cleft palate), cardiovascular defects (transposition of great vessels), and CNS anomalies (hydrocephalus). Due to its high lipid solubility and long half-life, it is strictly contraindicated in pregnancy (FDA Category X). **Incorrect Options:** * **Niacin (Vitamin B3):** Deficiency causes Pellagra (Dermatitis, Diarrhea, Dementia, Death), but it is not associated with the structural teratogenicity seen with retinoids. * **Thiamine (Vitamin B1):** Deficiency leads to Beriberi or Wernicke-Korsakoff syndrome. It is essential for carbohydrate metabolism and is safe during pregnancy. * **Folic Acid (Vitamin B9):** Unlike retinoids, folic acid is **protective**. Supplementation is mandatory periconceptionally to prevent **Neural Tube Defects (NTDs)** like spina bifida. **High-Yield Clinical Pearls for NEET-PG:** * **Isotretinoin Rule:** Female patients must use two forms of contraception and have two negative pregnancy tests before starting therapy (iPLEDGE program). * **Critical Period:** The most sensitive period for teratogenicity is organogenesis (**weeks 3 to 8** of gestation). * **Other Classic Teratogens:** * **Thalidomide:** Phocomelia (seal-like limbs). * **Valproate:** Neural tube defects (inhibits folate). * **Warfarin:** Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * **Phenytoin:** Fetal Hydantoin Syndrome (cleft lip/palate, hypoplastic nails).

Q: Good clinical practices (GCP) are not a part of which of the following trial phases?

Pre-clinical trials. **Explanation:** **Good Clinical Practice (GCP)** is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of **human subjects**. 1. **Why Pre-clinical trials is the correct answer:** Pre-clinical trials are conducted in **laboratories and on animal models** (in vitro and in vivo) to assess safety and biological activity before a drug is tested in humans. Because GCP specifically governs research involving human participants, it does not apply here. Instead, pre-clinical studies must adhere to **Good Laboratory Practices (GLP)** and guidelines for animal ethics. 2. **Why the other options are incorrect:** * **Phase I (Human Pharmacology):** Focuses on safety and dosage in a small group of healthy volunteers. Since humans are involved, GCP is mandatory. * **Phase II (Therapeutic Exploratory):** Focuses on efficacy and side effects in a small group of patients. GCP compliance ensures patient safety and data integrity. * **Phase IV (Post-Marketing Surveillance):** Occurs after the drug is marketed to detect rare adverse effects. Even in this observational phase, GCP standards must be maintained to protect patient rights. **High-Yield Clinical Pearls for NEET-PG:** * **GCP Objective:** To ensure the rights, safety, and well-being of trial subjects are protected and that clinical trial data are credible. * **The Declaration of Helsinki:** This is the historical cornerstone document that forms the basis of GCP. * **Phase 0 Trials:** Also known as "Microdosing" studies; these also require GCP as they involve human subjects. * **GLP vs. GCP:** Remember: **GLP** = Laboratory/Animals; **GCP** = Clinical/Humans.

Q: What is the mechanism of action of thalidomide?

Immunomodulation. **Explanation:** Thalidomide is a complex drug originally introduced in the 1950s as a sedative, but it is now primarily classified as an **immunomodulatory imide drug (IMiD)**. **Why Immunomodulation is Correct:** Thalidomide exerts its effects through multiple pathways: 1. **TNF-α Inhibition:** It suppresses the production of Tumor Necrosis Factor-alpha (TNF-α), a potent pro-inflammatory cytokine. 2. **Cereblon Binding:** It binds to the protein **Cereblon**, part of an E3 ubiquitin ligase complex, leading to the degradation of transcription factors (like Ikaros and Aiolos) essential for B-cell and T-cell function. 3. **Anti-angiogenesis:** It inhibits the growth of new blood vessels by suppressing VEGF and bFGF. **Analysis of Incorrect Options:** * **A. Antimicrobial:** Thalidomide has no direct action against bacteria, viruses, or fungi. While used in Leprosy, it treats the *reaction* (ENL), not the *infection* (*M. leprae*). * **B. Antiemetic:** Though historically used for morning sickness (leading to the thalidomide tragedy), it is no longer indicated or classified as an antiemetic due to extreme toxicity. * **C. Anti-allergic:** It does not stabilize mast cells or block histamine receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Current Indications:** 1. **Erythema Nodosum Leprosum (ENL):** Drug of choice for Type 2 Lepra reaction. 2. **Multiple Myeloma:** Used in combination with dexamethasone. * **Teratogenicity:** It is a potent human teratogen causing **Phocomelia** (seal-like limbs) if taken during the first trimester (specifically days 27–40 of gestation). * **Side Effects:** Peripheral neuropathy (most common dose-limiting toxicity) and thromboembolism.

Q: When used in the management of inflammatory disorders, glucocorticoids are likely to cause which of the following?

Increase in intraocular pressure. **Explanation:** Glucocorticoids (GCs) are steroid hormones that exert widespread metabolic and physiological effects. The correct answer is **D. Increase in intraocular pressure (IOP).** **Why it is correct:** Glucocorticoids can cause ocular hypertension and secondary open-angle glaucoma. They increase IOP by increasing the resistance to aqueous humor outflow through the trabecular meshwork. This occurs due to the accumulation of glycosaminoglycans and specific proteins (like myocilin) in the trabecular meshwork, which obstructs drainage. **Why the other options are incorrect:** * **A. Hypoglycemia:** GCs are "diabetogenic." They stimulate gluconeogenesis and decrease peripheral glucose uptake, leading to **hyperglycemia**, not hypoglycemia. * **B. Decreases in blood pressure:** GCs have weak mineralocorticoid activity, leading to sodium and water retention. They also sensitize vascular smooth muscle to catecholamines, typically causing **hypertension**. * **C. Anabolic actions in wound healing:** GCs are primarily **catabolic**. They inhibit fibroblast proliferation and collagen synthesis, which leads to delayed wound healing and skin thinning (striae). **High-Yield Clinical Pearls for NEET-PG:** * **Cushingoid Side Effects:** Remember the mnemonic **"CUSHINGOID"**: **C**ataracts (Posterior Subcapsular), **U**lcers (Peptic), **S**triate/Skin thinning, **H**ypertension/Hirsutism, **I**mmunosuppression, **N**ecrosis (Avascular necrosis of femoral head), **G**lucose elevation, **O**steoporosis, **I**OP increase, **D**epression/Psychosis. * **Osteoporosis:** GCs are the most common cause of drug-induced osteoporosis (they inhibit osteoblasts and decrease calcium absorption). * **Growth:** In children, GCs cause growth retardation due to interference with growth hormone action and epiphyseal closure.

Question 1

Alcohol, salicylates, and pilocarpine can be used as:

Accepted Answer

Diaphoretics

Answer

Chelating agents

Answer

Purging agents

Answer

Agents for forced alkaline diuresis

Question 2

Therapeutic drug monitoring of plasma concentration of antihypertensive drugs is not practiced because?

Accepted Answer

It is easier to measure the effect of these drugs.

Answer

Determination of plasma level of these drugs is a tedious and lengthy process.

Answer

The antihypertensive effect does not increase linearly with the dose.

Answer

All antihypertensive drugs are prodrugs.

Question 3

Fexofenadine is a metabolic product of which of the following drugs?

Accepted Answer

Terfenadine

Answer

Loratadine

Answer

Astemizole

Answer

Cetirizine

Question 4

Which of the following is not a pro-drug?

Accepted Answer

Penicillin

Answer

Becampicillin

Answer

Levodopa

Answer

Enalapril

Question 5

Which of the following is/are prodrug(s)?

Accepted Answer

All the above

Answer

Proguanil

Answer

Azathioprine

Answer

Prontosil

Question 6

Which of the following drugs can result in the teratogenic effect shown in the diagram if given during pregnancy?

Accepted Answer

Retinoic acid

Answer

Niacin

Answer

Thiamine

Answer

Folic acid

Question 7

In which of the following phases of a clinical trial is ethical clearance not required?

Accepted Answer

Phase IV

Answer

Phase I

Answer

Phase II

Answer

Phase III

Question 8

Good clinical practices (GCP) are not a part of which of the following trial phases?

Accepted Answer

Pre-clinical trials

Answer

Phase I Clinical Trials

Answer

Phase II Clinical Trials

Answer

Phase IV clinical trials

Question 9

What is the mechanism of action of thalidomide?

Accepted Answer

Immunomodulation

Answer

Antimicrobial

Answer

Antiemetic

Answer

Anti-allergic

Question 10

When used in the management of inflammatory disorders, glucocorticoids are likely to cause which of the following?

Accepted Answer

Increase in intraocular pressure

Answer

Hypoglycemia

Answer

Decreases in blood pressure

Answer

Anabolic actions in wound healing

General Pharmacology — MCQs

General Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?